4 Undervalued Trading Companies & Distributors Stocks for Tuesday, November 12
Discover the top 4 undervalued Trading Companies & Distributors stocks for Tuesday, November 12 based on AAII’s Stock Grades.Omar Beirat
| SECTOR | INDUSTRY |
| Industrials | Trading Companies & Distributors |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Omar Beirat
Grace Malone
Eunice Kim
Jack Gilleland
| Share Statistics | BGLC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.8 | $5,412.6 | 2% |
|
| Shares Out (Mil) | 2.4 | 37.4 | 8% |
|
| Institutional Ownership | 1.4% | 63.2% | 2% |
|
| Float (Mil) | 0.8 | 47.9 | 2% |
|
| Beta | na | 0.92 | na |
|
| Avg Daily Volume (000s) | 13 | 190 | 18% |
|
| Price Change (52-week) |
(70.1%) | 82.9% | 9% |
|
| Growth | BGLC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (8.3%) | 8.9% | 6% |
|
| Net Income (5yr) | (36.4%) | 11.3% | 11% |
|
| EPS (5yr) | (26.7%) | 12.7% | 10 |
|
| Dividends (5yr) | 0.0% | 2.9% | 0% |
|
| Cash Flow (5yr) | (16.0%) | (9.8%) | 46% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BGLC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3 | $3,909 | 4% |
|
| Net Income (TTM) (Mil) | ($3) | $153 | 36% |
|
| EPS (TTM) | ($1.188) | $1.500 | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | $276 | 31% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $5 | 46% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $641 | 10% |
|
| Enterprise Value (Q1) (Mil) | $1 | $6,147 | 4% |
|
| Valuation | BGLC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.49 | 2.72 | 8% |
|
| P/E | na | 26.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | BGLC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 12.3% | 27.5% | 11% |
|
| Net Margin | (82.4%) | 3.8% | 9% |
|
| ROA | (28.4%) | 4.2% | 17% |
|
| ROE | (33.7%) | 12.3% | 19% |
|
| Liabilities to Assets | 10.9% | 57.0% | 6% |
|
| F-Score | 2 | 5 | 7% |
|
BioNexus Gene Lab Corp. did not pass any screens on 8/21/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors